Company Filing History:
2 out of 832,843 Years Active: 2002-2004
Title: Mark Philip Williams: Innovator in Papillomavirus Research
Introduction
Mark Philip Williams is an accomplished inventor based in Annerley, Australia. He has made significant contributions to the field of papillomavirus research, holding a total of 2 patents. His work focuses on developing innovative solutions for preventing and treating HPV infections.
Latest Patents
Williams' latest patents include groundbreaking advancements in papillomavirus polyprotein constructs. One patent describes a papillomavirus polyprotein construct that comprises at least two amino acid sequences fused together. Each sequence corresponds to an early ORF protein of papillomavirus or an immunogenic variant or fragment thereof. This invention also includes nucleic acid molecules encoding the polyprotein construct, as well as prophylactic or therapeutic compositions that utilize these constructs to elicit an immune response against papillomavirus in host animals.
Another patent focuses on peptides, antibodies, and recombinant expression systems that express a DNA insert of HPV. This invention aims to produce immunogenic compositions that can inhibit and treat HPV infections and tumor initiation and progression. Specific peptides and recombinant cells, such as vaccinia virus and tumor cells expressing regions of the HPV16 E6 or E7 nucleoprotein, are particularly highlighted in this patent.
Career Highlights
Throughout his career, Mark Philip Williams has demonstrated a commitment to advancing medical research and innovation. His patents reflect a deep understanding of molecular biology and immunology, showcasing his ability to translate complex scientific concepts into practical applications.
Collaborations
Williams has collaborated with notable colleagues in his field, including Elizabeth Ann Webb and Mary Brigid Margetts. These partnerships have likely contributed to the success of his research and the development of his patents.
Conclusion
Mark Philip Williams is a prominent inventor whose work in papillomavirus research has the potential to impact public health significantly. His innovative patents and collaborations highlight his dedication to advancing medical science and improving treatment options for HPV infections.